Connect your AI

Opus Genetics IRD Temporary Equity Shares Outstanding

Temporary Equity Shares Outstanding at other companies

Prospect CapitalPSEC

70.2M-1.3%

BillionToOne, Inc. BLLN

0-100%

Asset EntitiesASST

4.4M—

FCR

FutureCrest Acquisition FCRS

$28.75M—

Perella Weinberg PartnersPWP

21.9M-16.3%

FIP

FTAI Infrastructure Inc.FIP

20%—

Other financials

Income statement

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

Operating cash flow-$12.7M-41.5%

Valuation

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept us-gaap:TemporaryEquitySharesOutstanding.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's temporary equity shares outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Opus Genetics's temporary equity shares outstanding?: Opus Genetics (IRD) reported temporary equity shares outstanding of 7.4M in Q1 2026.